Icatibant Acetate

Product description

Icatibant Acetate is a selective competitive antagonist for the bradykinin B2 receptor. It is indicated for the treatment of acute attacks of hereditary angioedema (HAE). HAE is a rare disorder resulting in periodic attacks of acute edema. It is characterized by a deficiency of functional C1 esterase inhibitor that leads to the overproduction of bradykinin, which triggers vasodilation, vascular permeability, and edema. Icatibant Acetate inhibits bradykinin from binding to the B2 receptor and thereby treats the clinical symptoms of an acute, episodic attack of HAE.
Read more


CAS Registry Number 130308-48-4
Categories APIs (Active Pharmaceutical Ingredients); Contract Services - Contract ServicesContract Manufacturing; APIs (Active Pharmaceutical Ingredients)Peptides
Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; North America (USA, Canada)
Supplied from Switzerland; United States

More products from Bachem AG

View all our products (24)

Products from other suppliers